We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Kasia Lipska

Kasia Lipska

Dr. Lipska is an endocrinologist at the Yale School of Medicine and a Clinical Investigator at the Yale-New Haven Hospital Center for Outcomes Research and Evaluation (CORE). She completed her medical training at Harvard Medical School and her internal medicine training at the Brigham and Women’s Hospital. She spent a year taking care of patients with diabetes on the Navajo reservation and then went on to complete her endocrine training and the Robert Wood Johnson Clinical Scholars Program at the Yale School of Medicine. She spent a year in South India as part of a Fogarty sponsored fellowship pursuing research on cerebrovascular complications of diabetes. She is currently Instructor in the Department of Medicine and she conducts research to better understand the balance of harms and benefits of glucose-lowering therapy in older adults with type 2 diabetes. In addition, Dr. Lipska works at CORE on the development of ambulatory care quality measures for the Centers for Medicare & Medicaid Services (CMS). She is currently leading the development of an outcome measure of care quality among people with diabetes mellitus.

Disclosures

Dr. Lipska reports research funding from NIH and ADA/ASP. She also receives support from the Centers for Medicare & Medicaid Services (CMS) to develop publically reported quality measures.